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ABSTRACT
Background/aims A retrospective consecutive case
series to evaluate the efﬁcacy of re-operation in patients
with persistent or recurrent idiopathic full-thickness
macular hole after initial surgery with internal limiting
membrane peel (ILM).
Methods 491 patients underwent surgery for full-
thickness macular hole from January 2004 to November
2007. Fifty-ﬁve patients either did not close or reopened
during the follow-up period. Thirty patients with initial
ILM peel underwent repeat surgery involving vitrectomy,
enlargement of ILM rhexis and gas tamponade.
Results Anatomical closure rate was 88.8% for primary
surgery and 46.7% (14/30) for re-operation. There was
a statistically signiﬁcant improvement in overall best
corrected visual acuity (BCVA) from re-operation baseline
BCVA (p¼0.02) within 1 year. For holes that did not
close after the second surgery, visual acuity did not
worsen.
Conclusion Re-operation has a reduced success rate of
anatomical closure. However, BCVA is statistically
signiﬁcantly improved from re-operation baseline, so
even though we cannot return vision to pre-pathological
baseline, re-operation can improve on this new baseline.
INTRODUCTION
In 1991, Kelly and Wendel introduced a surgical
procedure to close macular holes, a previously
untreatable cause of poor and distorted central
vision. By 1993, they had achieved an anatomical
closure rate of 73% and a visual improvement rate
for two or more lines of 55%.
1 Retinal surgeons
globally have been reﬁning the technique for
macular hole surgery ever since, and hole closure
rates have been reported as exceeding 90% in some
publications.
2e8 Currently, the standard technique
is pars plana vitrectomy with gas tamponade, with
or without internal limiting membrane (ILM)
peeling.
Many studies conclude that peeling the ILM
improves hole closure rate, yet it remains some-
what controversial.
2 79 e14 The primary objective of
this study was to evaluate the efﬁcacy of re-oper-
ation in patients with persistent or recurrent idio-
pathic full-thickness macular hole after initial
surgery with ILM peel.
MATERIALS AND METHODS
Type of study
A retrospective interventional consecutive case
series was conducted.
Patients
The study population consisted of 491 consecutive
full-thickness macular hole surgical cases from
January 2004 to November 2007 from three retinal
surgeons working at two tertiary care teaching
hospitals in Toronto, Ontario, Canada. We
reviewed all their records in this time period and
did full chart reviews on patients who underwent
re-operation.
Data collection
Data were collected by reviewing the charts that
had macular hole surgery listed in the operating
room booking records, and manually identifying
the charts for patients that underwent a second
macular hole operation. The patients’ referring
ophthalmologists or optometrists were called for
more information if follow-up with their retinal
surgeon was not of sufﬁcient length. The
following data were obtained: age; sex; estimated
date of initial visual complaint, date of ﬁrst and
second operation; stage of the macular hole and
posterior vitreous detachment (PVD) status
before ﬁrst operation; baseline best corrected
visual acuity (BCVA) before ﬁrst and second
operations, and at 3 months, 6 months and 1 year
after re-operation; baseline lens status before ﬁrst
operation and at BCVA after re-operation;
macular hole conﬁguration determined by optical
coherence tomography (OCT) when available
before re-operation as described by Hillenkamp
et al; and fellow eye status with regards to
macular hole.
15
Primary surgical technique
The three retina surgeons involved performed
macular hole surgery using a similar technique. It
consisted of a standard three-port pars plana
vitrectomy with induction of a PVD as appro-
priate. All procedures involved ILM peel with
indocyanine green (ICG) dye. The three surgeons
involved had different ICG staining techniques.
Two of the surgeons mixed and diluted the ICG
with a 5% dextrose solution, and injected it onto
the posterior pole in a ﬂuid-ﬁlled eye. The third
surgeon mixed and diluted the ICG in Viscoat,
Alcon, Inc, Huenenberg, Switzerland, and injected
it onto the posterior pole with the infusion clamped.
All three surgeons aspirated the ICG immediately
after injection. All patients had gas tamponade with
either non-expansile C3F8 (14e15%) or SF6 (20%)
tamponade. All patients were then instructed to lie
face-down 90% of the time for 1 week.
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Clinical scienceRe-operation surgical technique
The three retina surgeons performed a similar procedure.
Re-operation began with a standard three-port pars plana
vitrectomy, followed by enlargement of the ILM rhexis with
adjunctive ICG staining. Autologous serum was used as an
adjuvant in four of 30 cases. All patients then had gas tampo-
nade with a non-expansile concentration of C3F8 gas, and were
subsequently instructed to lie face-down 90% of the time for
1 week.
Statistical methods
A paired two-tailed t test was performed with SAS software.
Patients had to have data for at least two of the three time
points (3 months, 6 months and 1 year post re-operation) to be
included in the statistical analysis. Data were carried forward in
the event of missing data. Counting ﬁngers was translated as
0.01 and hand motions as 0.0033 in decimal Snellen notation.
RESULTS
There was no statistically signiﬁcant difference between closed
and unclosed populations in terms of sex, age at re-operation or
time between surgeries. Further, we estimated the duration of
the hole as the difference between re-operation date and the
approximate date of initial visual complaint. Again, there was
no statistically signiﬁcant difference between closed and
unclosed populations based on estimated duration of symptoms.
There was an 88.8% closure rate (436/491) for primary
macular hole surgery in our study. All 25 patients that failed
initial macular hole surgery and were not re-operated on
declined re-operation either for personal reasons (a combination
of difﬁculty with face-down positioning along with guarded
prognosis) or deferred their decision to think about it and did not
get back to their surgeon within a year of primary surgery. We,
therefore, believe the conclusions of this paper apply to these
patients as well. Five of 30 re-operated patients were excluded
from the analysis because they did not have data for at least two
of the three follow-up time points. Two patients underwent
a third macular hole surgery within the 1-year period following
re-operation for failure to close, and they were included in the
analysis as intent to treat (ﬁgure 1).
There was a 46.7% success rate for re-operation (n¼30). Four
of the 25 holes included in the statistical analysis (for meeting
the requisite number of follow-up time points) reopened after
initial macular hole surgery; only one out of the four (25%)
closed following re-operation. We strictly deﬁned reopening as
macular hole closed on examination at 3 months, and found to
be open thereafter. Twenty-one of the 25 macular holes included
in the analysis were unclosed after initial operation; eleven of
these 21 closed (52%) after re-operation.
There was a statistically signiﬁcant improvement between
overall BCVA and re-operation baseline (p¼0.020) (ﬁgure 2).
Overall BCVA takes each patient’s highest visual acuity at any
point within 1-year postoperatively. Examining only patients
who achieved anatomical closure following re-operation, this
improvement was also signiﬁcant (n¼12, p¼0.038) (ﬁgure 3).
Examining only patients whose holes did not close after re-
operation (n¼13), their visual acuity did not decrease (ﬁgure 4).
Of our 13 patients with optical coherence tomography (OCT)
prior to re-operation, seven had cuffs of subretinal ﬂuid as per
Hillenkamp et al, and six did not.
15 Anatomical closure was
achieved in 71% of those with this cuff and only 50% of those
without.
At overall BCVA measurement for our 25 analysed patients,
13 were classiﬁed as pseudophakic, four had cataract formation
and eight did not have lens status recorded on chart review. Of
the four patients with cataracts, one had 1+nuclear sclerosis
(NS), one had 2+NS and two had 3+NS.
DISCUSSION
Despite the high success rate of macular hole surgery, it is not
100%. There have been many studies dedicated to this subset of
macular hole patients who fail to close. The current success rate
of primary surgery is 80e95%.
2e8 Valldeperas et al reported a
retrospective case series of 532 patients who underwent macular
hole surgery, but with only the rare ILM peel. Re-operation
on 52 unclosed holes yielded a 76% anatomical closure rate.
Re-operation on 21 reopened holes yielded a 100% anatomical
closure rate. They deﬁned reopened as holes that appeared closed
on examination, but then were found to be open again at a later
date. This reopening typically took place several months later.
16
Ours is the largest case series on macular hole re-operation on
a patient population whose ILM was routinely peeled during
primary surgery. The 88.8% success rate of primary surgery with
this technique is consistent with that reported elsewhere in the
literature on primary macular hole surgery.
2e8 Re-operation
with this technique yields a reduced anatomical success rate of
hole closure (46.7%, n¼30) compared with primary surgery.
Note that only 25 of the 30 re-operated patients were included
in the analysis because the other ﬁve did not have data for at
least two out of three of the follow-up time points. We achieved
a 52% closure rate with re-operation of unclosed holes (n¼21)
and 25% for reopened holes (n¼4). These are both much lower
Figure 1 Patient outcomes.
Figure 2 Best corrected visual acuity (BCVA) for all patients. VA,
visual acuity.
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to difference in technique. In their study, ILM peeling was rarely
carried out in both initial surgery and re-operation. We, there-
fore, hypothesise that re-operation is much less likely to succeed
in patients whose ILMs have already been peeled; there is little
else to do when the posterior hyaloid has been detached and the
ILM removed.
Of importance, overall BCVAwas signiﬁcantly improved from
re-operation baseline. It is also noteworthy that repeat surgery
did not worsen overall BCVA in the subset of patients whose
macular holes remained. Overall BCVA takes each patient’s
highest visual acuity at any point within 1 year postoperatively.
This approach was taken to guard against confounding factors
such as cataract progression, as macular hole surgery accelerates
cataract formation.
16 For example, a patient with successful
re-operation may have a decrease in visual acuity from 6 months
to 1 year postoperatively solely due to a new surgery-induced
cataract. Clinically, however, 88% of patients (22 of 25) did not
improve by at least one Snellen line; 8% (two of 25) improved by
two lines and 4% (one of 25) improved by four lines. We
hypothesise that the poor visual acuity outcomes relative to
primary surgery relate to the added duration of the hole, and
having to wait for and undergo a second surgery. It is often
difﬁcult to ascertain how long a hole has been present. Second,
we know that longer duration holes tend to be bigger and less
likely to close, so the ones that have failed may already be
predisposed to worse outcomes. Moreover after the ILM has
been peeled, residual ILM is more adherent. Additional surgical
trauma damages retinal pigment epithelium and photoreceptors,
and is probably an important component of disappointing visual
results.
While estimated duration of macular hole was recorded, it is
unreliable so it was not analysed as a variable with respect to
macular hole prognosis. Patients are often inaccurate in dating
the onset of symptoms. Macular holes are usually a monocular
disease process, so patients may not notice symptoms for some
time.
Hillenkamp et al performed a retrospective consecutive case
series of 28 unclosed macular holes. Each patient underwent
OCT prior to the repeat macular hole surgery. An elevated cuff
of subretinal ﬂuid at the margin of the macular hole (and over-
lapping it) was found to be a strong prognostic indicator for
both anatomical closure (p¼0.001) and BCVA improvement
(p¼0.048). This is contrasted with a ﬂat, punched out hole with
no distinct retinal cuff on OCT. To account for these ﬁndings, it
was proposed that there is lack of adhesion between the macular
hole margin and the underlying retinal pigment epithelium in
cases with an elevated cuff of subretinal ﬂuid at the margin of
the macular hole. This may facilitate closure of the macular hole.
This assumes that closure involves the centripetal movement of
retinal tissue to occupy the foveal region
15 (ﬁgure 5). OCTwas
not done routinely preoperatively in our patient population. So
while our limited data supports Hillenkamp’s conclusion, that
this cuff of subretinal ﬂuid is a prognostic factor in macular hole
surgery, our small sample size of 13 patients with OCTs does not
allow us to draw any deﬁnitive conclusions.
ILM peeling began in 1992 in the belief that it would help
prevent the reopening of macular holes.
10 It is believed that the
ILM acts as a scaffold for contractile tissue to exert tangential
traction on macular holes, leading to reopening.
2 In light of the
hypothesis that macular holes are closed by glial cell prolifera-
tion, Sheidow et al also propose that a surgeon can induce
a relatively consistent degree of trauma to facilitate this gliosis
over a macular hole by utilising ILM peeling.
7 An additional
beneﬁt is that the removal of ILM also reduces the chance of
epiretinal membrane formation.
14
Moreover, we hypothesise that with ILM peeling, all vitreal
traction should be removed. The majority of failures with our
technique were unclosed holes (76.9%). The causal mechanism
of these holes that reopened remains unclear. We believe that
elevation of the posterior hyaloid and removal of the ILM, as can
Figure 3 Best corrected visual acuity (BCVA) for patients with
anatomical closure.
Figure 4 Best corrected visual acuity (BCVA) for patients that did not
achieve anatomical closure. VA, visual acuity.
Figure 5 The optical coherence tomography (OCT) image on the left
shows an elevated cuff of subretinal ﬂuid at the margin of the macular
hole. According to Hillenkamp et al, it was found to be a strong prognostic
indicator for both anatomical closure (p=0.001), and best corrected visual
acuity improvement (p=0.048). This is in comparison to the OCT image
on the right of a ﬂat, punched out macular hole with no distinct retinal
cuff. Reproduced with permission from Hillenkamp J, et al.
15
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lone and ICG staining respectively, not only removes the
centripetal traction that is present, but also ensures that any
residual vitreous adherent to the retinal surface is removed.
Certainly the difﬁculties of face-down positioning and
non-compliance are likely to be important contributors, as may
be hole size and presence of the hole for longer than is realised.
The weaknesses of this study include the retrospective
nature of the data collection, involving three surgeons, and not
having data for hole size as preoperative OCTs were not
universally performed. Further, cataracts present a signiﬁcant
cofounder for BCVA.
17 Moreover, as some of the patients
declined a re-operation, this study had a limited sample size
with limited statistical power.
Ultimately, the decision to proceed with repeat macular hole
surgery must be done after careful deliberation with the patient,
informing the patient of the beneﬁts, risks, and the likelihood of
hole closure and visual acuity improvement. We hope that our
study will help inform this decision-making process when
considering re-operation after failed macular hole surgery with
ILM peel.
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